ArticleJournal for immunotherapy of cancer2018
Design considerations for early-phase clinical trials of immune-oncology agents.
Nolan A Wages et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled ittrialcites it